ピルトブルチニブ（LY3527727）の長期安全性を評価するためのマスタープロトコル

基本情報

NCT ID

NCT06876649

ステータス

募集中

試験のフェーズ

第4相

試験タイプ

介入

目標被験者数

787

治験依頼者名

Eli Lilly and Company

概要

The master protocol study J2N-MC-JZNY provides a framework to enable the evaluation of the long-term safety and efficacy of pirtobrutinib after completion of clinical studies evaluating pirtobrutinib. The clinical studies that will feed into this master protocol are referred to as originator studies. The master protocol will govern individual study-specific appendices (ISAs) that will represent participants from the individual, completed originator studies. These participants will have the opportunity to enter this study and continue to receive treatment or continue follow-up visits. Overall, the master protocol and the individual ISAs, when combined, define the investigations for this study.

対象疾患

介入

依頼者（Sponsor）

実施施設 (7)